Ocuphire Pharma, Inc.
Clinical trials sponsored by Ocuphire Pharma, Inc., explained in plain language.
Ophthalmology company developing therapies for retinal and refractive eye conditions.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New eye drops aim to banish night glare after laser surgery Results expected Aug 2027 (estimated) 🚀 Make-or-break